Skip to main content
. 2022 Apr 7;13(4):9302–9312. doi: 10.1080/21655979.2022.2051854

Table 1.

Correlation between HCP5 expression and clinicopathological features in ESCC patients (n = 86)

Parameters All cases HCP5 expressiona
P value
Low (n = 43) High (n = 43)
Gender        
Male 50 23 27 0.382
Female 36 20 16
Age (years)        
≤ 65 44 25 19 0.196
> 65 42 18 24
Tumor size        
≤ 3 34 23 11 0.008
> 3 52 20 32
Differentiation        
Well/moderate 48 28 20 0.082
Poor 38 15 23
TNM stage        
I–II 56 34 22 0.007
III–IV 30 9 21
Lymph node metastasis        
No 53 35 18 <0.001
Yes 33 8 25
Smoking        
No 35 15 20 0.272
Yes 51 28 23
Drinking        
No 47 25 22 0.516
Yes 39 18 21

aThe median HCP level was used as the cuf-off value.